VITILIGO: ETIOLOGY, CLINICAL FEATURES AND MODERN TREATMENT APPROACHES
Keywords:
vitiligo, depigmentation, melanocytesAbstract
Vitiligo is a chronic skin disorder characterized by the loss of melanocytes, leading to depigmented white patches on the skin. The disease affects approximately 1–2% of the global population and can occur at any age. Although vitiligo does not directly threaten life, it has significant psychological and social impacts. The aim of this article is to review the etiology, clinical manifestations, pathogenesis, and modern treatment approaches of vitiligo. Understanding the mechanisms of melanocyte destruction and immune dysregulation is essential for improving diagnostic and therapeutic strategies.
References
1. Krüger C., Schallreuter K. The worldwide prevalence of vitiligo. International Journal of Dermatology.
2. Taieb A., Picardo M. Vitiligo. New England Journal of Medicine.
3. World Health Organization – Skin disorders and public health reports.
4. American Academy of Dermatology – Vitiligo clinical guidelines.
5. National Institutes of Health – Vitiligo research publications.
